Buzy Peter L

Avg. Two Year Performance

(< 1%) Avg. Purchase Return
0% Compound
10% Avg. Sale Return
5% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%1%2%2%(< 1%)
Purchase Success Rate1 of 21 of 21 of 21 of 20 of 2
Average Sale Return(6%)(10%)(25%)(7%)10%
Sale Success Rate1 of 20 of 20 of 20 of 21 of 2

Martek Biosciences Corp.

Drugs » Biotechnology

CFO, Treasurer and Exec VP:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Catalent, Inc.

Drugs » Drugs - Generic

President, Gene Therapy:

Holdings: 45.95K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--